Gene silencing of chordin improves BMP-2 effects on osteogenic differentiation of human adipose tissue-derived stromal cells

Tissue Engineering - Part A

Volumn 20, Issue 1-2, 2014, Pages 335-345

  Schneider, Hellen ^a   Sedaghati, Bita ^a   Naumann, Andreas ^b   Hacker, Michael C ^a   Schulz Siegmund, Michaela ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC ENGINEERING; MINERALOGY; STEM CELLS; TISSUE;

BONE MORPHOGENIC PROTEIN; GENE SILENCING; HUMAN MESENCHYMAL STEM CELLS; INDIVIDUAL DIFFERENCES; MATRIX MINERALIZATION; OSTEOGENIC DIFFERENTIATION; OSTEOGENIC EFFECTS; TRANSFECTION REAGENTS;

CYTOLOGY;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CHORDIN; NOGGIN; SMALL INTERFERING RNA;

ADIPOSE TISSUE; ADIPOSE TISSUE DERIVED STROMA CELL; ARTICLE; BIOMINERALIZATION; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPOSOMAL GENE DELIVERY SYSTEM; LIPOSUCTION; MALE; OSTEOGENIC DIFFERENTIATION; PRIORITY JOURNAL; STROMA CELL;

ADIPOSE TISSUE; ADULT; BONE MORPHOGENETIC PROTEIN 2; CARRIER PROTEINS; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPIDS; MALE; OSTEOGENESIS; RNA, MESSENGER; RNA, SMALL INTERFERING; STROMAL CELLS; TRANSFECTION;

EID: 84891547675     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0563     Document Type: Article

References (64)

1. Canalis, E., Economides, A., and Gazzerro, E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24, 218, 2003.
2. Chung, Y.-I., Ahn, K.-M., Jeon, S.-H., Lee, S.-Y., Lee, J.-H., and Tae, G. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. Fourth International Nanomedicine and Drug Delivery Symposium. J Controlled Release 121, 91, 2007.
3. Hughes, F.J., Collyer, J., Stanfield, M., and Goodman, S.A. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 136, 2671, 1995.
4. Ishikawa, H., Kitoh, H., Sugiura, F., and Ishiguro, N. The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passages. Acta Orthop 78, 285, 2007.
5. Dean, D.B., Watson, J.T., Jin, W., Peters, C., Enders, J.T., Chen, A., Moed, B.R., and Zhang, Z. Distinct functionalities of bone morphogenetic protein antagonists during fracture healing in mice. J Anat 216, 625, 2010.
6. Diefenderfer, D., Osyczka, A., Reilly, G., and Leboy, P. BMP responsiveness in human mesenchymal stem cells. Connect Tissue Res 44 Suppl 1, 305, 2003.
7. Kim, S. in, Song, Y.M., Cho, T.H., Park, Y.D., Lee, K.B., Noh, I., Weber, F., and Hwang, S.J. In vitro response of primary human bone marrow stromal cells to recombinant human bone morphogenic protein-2 in the early and late stages of osteoblast differentiation. Dev Growth Differ 50, 553, 2008.
8. Mizuno, D., Agata, H., Furue, H., Kimura, A., Narita, Y., Watanabe, N., Ishii, Y., Ueda, M., Tojo, A., and Kagami, H. Limited but heterogeneous osteogenic response of human bone marrow mesenchymal stem cells to bone morphogenetic protein-2 and serum. Growth Factors 28, 34, 2009.
9. Osyczka, A.M., Diefenderfer, D.L., Bhargave, G., and Leboy, P.S. Different Effects of BMP-2 on Marrow Stromal Cells from Human and Rat Bone. Cells Tissues Organs 176, 109, 2004.
10. Panetta, N., Gupta, D., Lee, J., Wan, D., Commons, G., and Longaker, M. Human adipose-derived stromal cells respond to and elaborate bone morphogenetic protein-2 during in vitro osteogenic differentiation. Plast Reconstr Surg 125, 483, 2010.
11. Zuk, P., Chou, Y.-F., Mussano, F., Benhaim, P., and Wu, B. Adipose-derived stem cells and BMP2: part 2. BMP2 may not influence the osteogenic fate of human adipose-derived stem cells. Connect Tissue Res 52, 119, 2011.
12. Takayama, K., Suzuki, A., Manaka, T., Taguchi, S., Hashimoto, Y., Imai, Y., Wakitani, S., and Takaoka, K. RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro. J Bone Miner Metab 27, 402, 2009.
13. Valentin-Opran, A., Wozney, J., Csimma, C., Lilly, L., and Riedel, G.E. Clinical Evaluation of Recombinant Human Bone Morphogenetic Protein-2. Clin Orthop Relat Res 395, 110, 2002.
14. Tsialogiannis, E., Polyzois, I., Tang, Q.O., Pavlou, G., Tsiridis, E., Heliotis, M., and Tsiridis, E. Targeting bone morphogenetic protein antagonists: in vitro and in vivo evidence of their role in bone metabolism. Expert Opin Ther Targets 13, 123, 2008.
15. Gazzerro, E., and Minetti, C. Potential drug targets within bone morphogenetic protein signaling pathways. Curr Opin Pharmacol 7, 325, 2007.
16. Zimmerman, L.B., Jesús-Escobar, J.M. de, and Harland, R.M. The spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86, 599, 1996.
17. Piccolo, S., Sasai, Y., Lu, B., and De Robertis, E.M. Dorsoventral patterning in xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86, 589, 1996.
18. Reddi, A.H. Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN. Arthritis Res 3, 1, 2001.
19. Gazzerro, E., Du, Z., Devlin, R.D., Rydziel, S., Priest, L., Economides, A.N., and Canalis, E. Noggin arrests stromal cell differentiation in vitro. Bone 32, 111, 2003.
20. Gazzerro, E., and Canalis, E. Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7, 51, 2006.
21. Petryk, A., Shimmi, O., Jia, X., Carlson, A., Tervonen, L., Jarcho, M., O'connor, M., and Gopalakrishnan, R. Twisted gastrulation and chordin inhibit differentiation and mineralization in MC3T3-E1 osteoblast-like cells. Bone 36, 617, 2005.
22. Tang, Y., Ye, X., Klineberg, E., Curtiss, S., Maitra, S., and Gupta, M. Temporal and spatial expression of BMPs and BMP antagonists during posterolateral lumbar fusion. Spine 36, E237, 2011.
23. Gazzerro, E., Gangji, V., and Canalis, E. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J Clin Invest 102, 2106, 1998.
24. Manaka, T., Suzuki, A., Takayama, K., Imai, Y., Nakamura, H., and Takaoka, K. Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation. Biomaterials 32, 9642, 2011.
25. Ramasubramanian, A., Shiigi, S., Lee, G., and Yang, F. Nonviral delivery of inductive and suppressive genes to adiposederived stem cells for osteogenic differentiation. Pharm Res 28, 1328, 2011.
26. Wan, D.C., Pomerantz, J.H., Brunet, L.J., Kim, J.-B., Chou, Y.- F., Wu, B.M., Harland, R., Blau, H.M., and Longaker, M.T. Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation. J Biol Chem 282, 26450, 2007.
27. Levi, B., Hyun, J., Nelson, E., Li, S., Montoro, D., Wan, D., Jia, F., Glotzbach, J., James, A., Lee, M., Huang, M., Quarto, N., Gurtner, G., Wu, J., and Longaker, M. Nonintegrating knockdown and customized scaffold design enhances human adipose-derived stem cells in skeletal repair. Stem Cells 29, 2018, 2011.
28. Chen, C., Uludag? , H., Wang, Z., and Jiang, H. Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells in vitro. J Cell Biochem 113, 3672, 2012.
29. Kwong, F.N.K., Richardson, S.M., and Evans, C.H. Chordin knockdown enhances the osteogenic differentiation of human mesenchymal stem cells. Arthritis Res Ther 10, R65, 2008.
30. Hoelters, J., Ciccarella, M., Drechsel, M., Geissler, C., Gülkan, H., Bö cker, W., Schieker, M., Jochum, M., and Neth, P. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells. J Gene Med 7, 718, 2005.
31. Canalis, E., Brunet, L.J., Parker, K., and Zanotti, S. Conditional Inactivation of Noggin in the Postnatal Skeleton Causes Osteopenia. Endocrinology 153, 1616, 2012.
32. Bunnell, B.A., Flaat, M., Gagliardi, C., Patel, B., and Ripoll, C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 45, 115, 2008.
33. Gimble, J.M. Adipose tissue-derived therapeutics. Expert Opin Biol Ther 3, 705, 2003.
34. Gimble, J.M., Katz, A.J., and Bunnell, B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 100, 1249, 2007.
35. Girolamo, L. de, Sartori, M.F., Albisetti, W., and Brini, A.T. Osteogenic differentiation of human adipose-derived stem cells: comparison of two different inductive media. J Tissue Eng Regen Med 1, 154, 2007.
36. Buettner, M., Moller, S., Keller, M., Huster, D., Schiller, J., Schnabelrauch, M., Dieter, P., and Hempel, U. Over-sulfated chondroitin sulfate derivatives induce osteogenic differentiation of human mesenchymal stromal cells independent of bone morphogenetic protein-2 and transforming growth factor-b1 signalling. J Cell Physiol 228, 330, 2013.
37. Berger, C., Montag, C., Berndt, S., and Huster, D. Optimization of Escherichia coli cultivation methods for high yield neuropeptide Y receptor type 2 production. Protein Expr Purif 76, 25, 2011.
38. Hillger, F. Biophysical comparison of BMP-2, ProBMP-2, and the free pro-peptide reveals stabilization of the pro-peptide by the mature growth factor. J Biol Chem 280, 14974, 2005.
39. Kirsch, T., Nickel, J., and Sebald, W. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J 19, 3314, 2000.
40. Katagiri, T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127, 1755, 1994.
41. Chen, C. Effects of macrophages and noggin suppression on the BMP-2-induced osteogenesis of human bone marrow mesenchymal stem cells [M. S. thesis]. Department of Surgery, University of Alberta, Edmonton, Alberta, 2010.
42. Diefenderfer, D.L., Osyczka, A.M., and Garino, J.P.L.P.S. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. J Bone Joint Surg 85-A, 19, 2003.
43. Lecanda, F., Avioli, L.V., and Cheng, S.-L. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 67, 386, 1997.
44. Stein, G.S., and Lian, J.B. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14, 424, 1993.
45. Krattinger, N., Applegate, L.A., Biver, E., Pioletti, D.P., and Caverzasio, J. Regulation of proliferation and differentiation of human fetal bone cells. Eur Cell Mater 21, 46, 2011.
46. Hyzy, S.L., Olivares-Navarrete, R., Schwartz, Z., and Boyan, B.D. BMP2 induces osteoblast apoptosis in a maturation state and noggin-dependent manner. J Cell Biochem 113, 3236, 2012.
47. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64, 295, 1997.
48. Jørgensen, N.R., Henriksen, Z., Sørensen, O.H., and Civitelli, R. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69, 219, 2004.
49. Lissenberg-Thunnissen, S.N., Gorter, D.J.J. de, Sier, C.F.M., and Schipper, I.B. Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 35, 1271, 2011.
50. Jäger, M., Fischer, J., Dohrn, W., Li, X., Ayers, D.C., Czibere, A., Prall, W.C., Lensing-Höhn, S., and Krauspe, R. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro. J Orthop Res 26, 1440, 2008.
51. Gimble, J.M., Bunnell, B.A., Chiu, E.S., and Guilak, F. Concise review: adipose-derived stromal vascular fraction cells and stem cells: let's not get lost in translation. Stem Cells 29, 749, 2011.
52. Corsi, K.A., Pollett, J.B., Phillippi, J.A., Usas, A., Li, G., and Huard, J. Osteogenic potential of postnatal skeletal musclederived stem cells is influenced by donor sex. J Bone Miner Res 22, 1592, 2007.
53. Hong, L., Sultana, H., Paulius, K., and Zhang, G. Steroid regulation of proliferation and osteogenic differentiation of bone marrow stromal cells: a gender difference. J Steroid Biochem Mol Biol 114, 180, 2009.
54. Phinney, D.G., Kopen, G., Righter, W., Webster, S., Tremain, N., and Prockop, D.J. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75, 424, 1999.
55. Siddappa, R., Licht, R., van Blitterswijk, C., and de Boer, J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25, 1029, 2007.
56. Kim, M., Kim, C., Choi, Y.S., Kim, M., Park, C., and Suh, Y. Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential: implication to age-associated bone diseases and defects. Mech Ageing Dev 133, 215, 2012.
57. Fickert, S., Schröter-Bobsin, U., Gross, A.-F., Hempel, U., Wojciechowski, C., Rentsch, C., Corbeil, D., and Günther, K.P. Human mesenchymal stem cell proliferation and osteogenic differentiation during long-term ex vivo cultivation is not age dependent. J Bone Miner Metab 29, 224, 2011.
58. Aksu, A.E., Rubin, J.P., Dudas, J.R., and Marra, K.G. Role of gender and anatomical region on induction of osteogenic differentiation of human adipose-derived stem cells. Ann Plast Surg 60, 306, 2008.
59. Leskelä, H.-V., Olkku, A., Lehtonen, S., Mahonen, A., Koivunen, J., Turpeinen, M., Uusitalo, J., Pelkonen, O., Kangas, L., Selander, K., and Lehenkari, P. Estrogen receptor alpha genotype confers interindividual variability of response to estrogen and testosterone in mesenchymal-stem-cell- derived osteoblasts. Bone 39, 1026, 2006.
60. Levi, B., and Longaker, M.T. Concise review: adiposederived stromal cells for skeletal regenerative medicine. Stem Cells 29, 576, 2011.
61. Ray, R., Novotny, N.M., Crisostomo, P.R., Lahm, T., Abarbanell, A., and Meldrum, D.R. Sex steroids and stem cell function. Mol Med 14, 493, 2008.
62. Arvidson, K., Abdallah, B.M., Applegate, L.A., Baldini, N., Cenni, E., Gomez-Barrena, E., Granchi, D., Kassem, M., Konttinen, Y.T., Mustafa, K., Pioletti, D.P., Sillat, T., and Finne-Wistrand, A. Bone regeneration and stem cells. J Cell Mol Med 15, 718, 2011.
63. Tang, X., Meng, H., Han, J., Zhang, L., Hou, J., and Zhang, F. Up-regulation of estrogen receptor-beta expression during osteogenic differentiation of human periodontal ligament cells. J Periodont Res 43, 311, 2008.
64. Oreffo, R.O., Kusec, V., Romberg, S., and Triffitt, J.T. Human bone marrow osteoprogenitors express estrogen receptoralpha and bone morphogenetic proteins 2 and 4 mRNA during osteoblastic differentiation. J Cell Biochem 75, 382, 1999.